Galderma Group AG (PY30)
FSX
Closed
Oct 23, 2026
Day's Range
38.8052 wk Range
28.00Overview - PY30 - Galderma Group AG
Key Statistics
Valuation
Enterprise Value
42.68B
P/E (Trailing)
62.53
Price / Sales (TTM)
7.75
Price / Book
6.28
EV / EBITDA
34.49
Profitability
Profit Margin
14.57%
Operating Margin
20.23%
Return on Assets
5.35%
Return on Equity
10.82%
Ownership
Shares Outstanding
234.56M
Float
656.33M
Held by Insiders
0.00%
Held by Institutions
0.01%
Price stats
Beta
-0.05
50-Day Avg
33.80
200-Day Avg
33.45
Dividends
Payout Ratio
12.13%
Frequency
Annual
Market Cap - PY30 - Galderma Group AG
Peers - PY30 - Galderma Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- PY30FSXGalderma Group AG45.93BMarket Cap+26.90%52-week change62.54P/E (Trailing)14.57%Profit Margin
- ANLFSXAnalog Devices, Inc.166.10BMarket Cap+40.40%52-week change47.41P/E (Trailing)29.78%Profit Margin
- PARFSXParker-Hannifin Corporation106.71BMarket Cap+24.11%52-week change35.14P/E (Trailing)16.96%Profit Margin
- MRKFSXMerck KGaA61.89BMarket Cap+19.67%52-week change27.43P/E (Trailing)11.21%Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR60.43BMarket Cap+23.24%52-week change24.95P/E (Trailing)11.21%Profit Margin
- H6DFSXHaleon Plc ADR39.35BMarket Cap+10.06%52-week change19.13P/E (Trailing)14.55%Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.35.50BMarket Cap-60.75%52-week change38.21P/E (Trailing)24.93%Profit Margin
Profile Summary - PY30 - Galderma Group AG
About
Galderma Group AG is a prominent player in the healthcare and dermatology sectors, renowned for its dedication to enhancing skin health. As a pharmaceutical company, it primarily focuses on research, development, and commercialization of dermatological solutions, driving innovation in the health and beauty markets.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
